safety
Showing 1 - 25 of 151
Clinical Benefits of Different Formulations of Amphotericin B
Active, not recruiting
- Efficacy
- Safety
-
Jinan, Shandong, ChinaRui Yang,MD
Nov 3, 2023
Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)
Recruiting
- Tumor Infiltrating Lymphocytes
- +4 more
- GC101 TIL
-
Beijing, ChinaBeijing Cancer Hospital
Nov 7, 2023
Efficacy, Safety, Pharmacokinetics Trial in Jilin (Hepenofovir Fumarate Tablets)
Recruiting
- Efficacy
- +2 more
- Hepenofovir Fumarate Tablets
-
Jilin, Changchun, ChinaThe First Hospital of Jilin University
Nov 2, 2023
Safety, Pharmacokinetics, Pharmacodynamics Trial in Overland Park (Kratom, Placebo)
Recruiting
- Safety
- +2 more
- Kratom
- Placebo
-
Overland Park, KansasAltasciences Clinical Kansas, Inc.
Oct 10, 2023
Health, Safety, Workplace Trial (GiochiAMO a 626)
Not yet recruiting
- Health
- +2 more
- GiochiAMO a 626
- (no location specified)
Sep 23, 2023
Safety, Acceptability, Usability Trial in Worldwide (Placebo Vaginal Film with Square Corners, Placebo Vaginal Film with Rounded
Not yet recruiting
- Safety
- +2 more
- Placebo Vaginal Film with Square Corners
- Placebo Vaginal Film with Rounded Corners
-
Pittsburgh, Pennsylvania
- +4 more
Sep 20, 2023
Refractory Diabetic Foot, Human Cord Blood-derived Mononuclear Cells, Efficacy Trial in Nanjing (human cord blood-derived
Recruiting
- Refractory Diabetic Foot
- +4 more
- human cord blood-derived mononuclear cells (HCB-MNCs)
-
Nanjing, Chinathe First Affiliated Hospital of Nanjing Medical University
Aug 13, 2023
Immune Response, Safety Trial in Incheon (bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza
Active, not recruiting
- Immune Response
- Safety
- bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
- quadrivalent influenza vaccine
-
Incheon, Seo-gu, Korea, Republic ofInternational St. Mary's hospital
Jul 28, 2023
Heart Failure, Electric Impedance, Dyspnea Trial in Córdoba (Diuretics withdrawal, Diuretics maintenance)
Recruiting
- Heart Failure
- +4 more
- Diuretics withdrawal
- Diuretics maintenance
-
Córdoba, Córdoba (Andalucía), SpainHospital Universitario Reina Sofía
Jul 25, 2023
Social Isolation, Well-being, Quality of Life Trial in Oslo (Offer to try Komp)
Enrolling by invitation
- Social Isolation
- +10 more
- Offer to try Komp
-
Oslo, Norway
- +2 more
Jun 16, 2023
Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic
Not yet recruiting
- Advanced Solid Tumor
- +4 more
- Cadonilimab
- Stereotactic body radiotherapy
-
Peking, Beijing, ChinaDepartment of radiation oncology, Peking University Third Hospit
Jun 20, 2023
Heart Failure, Levosimendan, Efficacy Trial in Jinan
Recruiting
- Heart Failure
- +3 more
-
Jinan, Shandong, ChinaFirst Affiliated Hospital of Shandong First Medical University (
Jun 17, 2023
Safety Trial in Alexandria (Intensive Care Nurses' Training Package)
Completed
- Safety
- Intensive Care Nurses' Training Package
-
Alexandria, Egypt
- +1 more
Jun 17, 2023
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))
Completed
- Safety
- +2 more
- RHN-001 (one tablet 750mg)
- RHN-001 (750mg * 2 Tablets)
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research (CBSCR),
Apr 26, 2023
Safety and Efficacy of Distal Radial Approach
Recruiting
- Safety
- Efficacy
-
Yongin, Gyeonggi-do, Korea, Republic ofYongcheol Kim
Mar 8, 2023
Bioavailability, Gut Microbiome, Safety Trial in Lubbock (Low curcumin group, High curcumin group)
Not yet recruiting
- Bioavailability
- +2 more
- Low curcumin group
- High curcumin group
-
Lubbock, TexasTexas Tech University Health Sciences Center
Mar 15, 2023
Breast Cancer With Liposomal Doxorubicin Regimen
Recruiting
- Breast Cancer
- +4 more
- Liposomal doxorubicin containing regimen
-
Hangzhou, Zhejiang, ChinaSecond Affiliate Hospital of Zhejiang University
Feb 7, 2023
Pharmacokinetics, Safety, Tolerability Trial in Overland Park (5-methoxy-N,N-dimethyltryptamine succinate salt, Placebo)
Recruiting
- Pharmacokinetics
- +2 more
- 5-methoxy-N,N-dimethyltryptamine succinate salt
- Placebo
-
Overland Park, KansasAltasciences Clinical Kansas, Inc
Jan 13, 2023
Safety, Bioavailability, Pharmacokinetics Trial in Ljubljana (Linaprazan glurate)
Completed
- Safety
- +2 more
- Linaprazan glurate
-
Ljubljana, Ukmarjeva Ulica 6, SloveniaCRS d.o.o.
Jan 17, 2023
Immunogenicity, Safety, Efficacy Trial in Savannakhét (SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2.,
Active, not recruiting
- Immunogenicity
- +2 more
- SW-BIC-213;SARS-Cov-2.
- +2 more
-
Savannakhét, Sava, Lao People's Democratic RepublicSavannakhét Provincial hospital
Jan 8, 2023
Prospective G7 Dual Mobility Total Hip PMCF
Enrolling by invitation
- Clinical Outcomes
- +4 more
- G7 Dual Mobility hip
-
Jersey City, New Jersey
- +5 more
Jan 12, 2023
T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)
Recruiting
- T-lymphoblastic Lymphoma
- +5 more
- BCL2 Inhibitor plus IM2 regimen
-
Shanghai, Shanghai, ChinaShanghai General hospital,Shanghai Jiao Tong University School o
Jan 10, 2023
Safety, Adverse Event Following Immunisation, Birth Outcomes Trial in Boston, Durham, Cincinnati (Quadrivalent Recombinant
Completed
- Safety
- +2 more
- Quadrivalent Recombinant Influenza Vaccine
- Quadrivalent Inactivated Influenza Vaccine
-
Boston, Massachusetts
- +2 more
Jan 9, 2023